Session translationnelle #3 : Neuropsycho- pharmacologie
lundi 12 juin 2023
Sessions translationnelles
Sessions translationnelles
•
S20
•
16h30
>
18h00
•
Session translationnelle #3 : Neuropsycho- pharmacologie
•
Amphi 400 C
Sessions translationnelles
Modérateurs : Louise CARTON (Lille), Edouard LAFORGUE (Nantes)
Conférence invitée
16h30 Dépression : les promesses et limites de la kétamine - Alain GARDIER (Paris)
Communications libres
•
148
•
17h00 - CO-034 - Reporting of Harms in Clinical Trials of Esketamine in Depression: A Systematic Review
>
T.
Tanguy
TAILLEFER DE LAPORTALIÈRE
•
12
•
17h10 - CO-031 - A significant proportion of methadone adverse effects are due to failure to take into account its pharmacological properties
>
T.
Thomas
Soeiro
•
51
•
17h20 - CO-032 - Association between clozapine plasma level and clinical outcomes - a first systematic review, meta-analysis and individual participant data meta-analysis
>
Z.
Zoubir
Djerada
•
107
•
17h30 - CO-033 - Blockade of CCK2R prevents the onset of vincristine-induced sensory neuropathy in mice
>
C.
Claire
Demiot
•
178
•
17h40 - CO-035 - Metabolomic profiles of 38 acylcarnitines in major depressive episodes before and after treatment: results from the METADAP and VARIETE cohorts
>
A.
Abd El Kader
Ait Tayeb
•
248
•
17h50 - CO-036 - Impact of BTK inhibitor ibrutinib on chronic kidney disease-induced cognitive impairment in rats
>
G.
Guillaume
Hache
|